Reports Archives - Page 3 of 5 - World Asthma Foundation

April 10, 2012

Targacept reports error in asthma study – Triad Business Journal

Targacept reports error in asthma study
Triad Business Journal
Targacept disclosed an error in the analysis of a potential asthma treatment, but says the candidate still holds promise. Targacept said an error in the analysis of a drug it recently studied as a potential treatment for asthma affected the results, …
Targacept Announces Revised Top-Line Results from Exploratory Phase 2 Study of …MarketWatch (press release)
Targacept Revises Results Of Exploratory Drug Study; Shares SlumpWall Street Journal
Targacept Reports Revised Top-Line Results From Phase 2 Study Of TC-6987NASDAQ
Benzinga
all 11 news articles »

View full post on asthma – Google News

April 10, 2012

Targacept Reports Revised Top-Line Results From Phase 2 Study Of TC-6987 – NASDAQ

Targacept Reports Revised Top-Line Results From Phase 2 Study Of TC-6987
NASDAQ
(RTTNews.com) – Targacept Inc. (TRGT) announced revised top-line results from its exploratory Phase 2 clinical study of TC-6987 in asthma. After identifying an error in the application of the agreed statistical analysis plan, a reanalysis of the data …
Targacept Announces Revised Top-Line Results from Exploratory Phase 2 Study of …MarketWatch (press release)
Targacept Announces Revised Top-Line Results from Exploratory Phase 2 StudyBenzinga

all 9 news articles »

View full post on asthma – Google News

March 28, 2012

Biota Reports Positive Phase IIb Data For Asthmatic Patients With HRV Infection – NASDAQ

Biota Reports Positive Phase IIb Data For Asthmatic Patients With HRV Infection
NASDAQ
The Phase II multicenter, randomized, double-blind, placebo controlled study in asthmatic adults with symptomatic, naturally acquired human rhinovirus infection was conducted over two consecutive seasons in 48 centers in the US Subjects received either …
Biota Announces Positive Phase IIb Data for Asthmatic Patients With Human …MarketWatch (press release)

all 6 news articles »

View full post on asthma – Google News

March 27, 2012

Targacept reports mixed data from two trials – Reuters

Targacept reports mixed data from two trials
Reuters
* Says asthma trial meets main goals * Says diabetes trial did not meet main goal * Targacept drops development of drug for diabetes March 27 (Reuters) – Targacept said an experimental drug proved effective in a mid-stage asthma trial, but failed to …
Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of …MarketWatch (press release)
Targacept Dropping Development Of Diabetes Drug; Shares FallWall Street Journal
Targacept Reports Top-Line Results From 2 Exploratory Phase 2 Studies Of TC-6987RTT News

all 14 news articles »

View full post on asthma – Google News

March 27, 2012

Targacept Reports Top-Line Results From 2 Exploratory Phase 2 Studies Of TC-6987 – RTT News

Targacept Reports Top-Line Results From 2 Exploratory Phase 2 Studies Of TC-6987
RTT News
(RTTNews) – Targacept Inc. (TRGT: News ) announced top-line results from two separate exploratory Phase 2 studies of its product candidate TC-6987 conducted in the US, one in asthma and one in type 2 diabetes. In the asthma study, oral TC-6987 met …
Targacept Announces Top-Line Results from Two Exploratory Phase 2 Studies of …MarketWatch (press release)

all 6 news articles »

View full post on asthma – Google News

February 20, 2012

Children’s Hospital reports progress on asthma – Boston Globe

Children's Hospital reports progress on asthma
Boston Globe
Hospitalizations for asthma have been dramatically cut by a program that helps families reduce the conditions that trigger attacks, saving $1.46 in hospital care for every $1 spent on prevention, according to a Children's Hospital Boston study being …
Home Visits for Asthma: A win for Both Patients and PayersMarketWatch (press release)

all 11 news articles »

View full post on asthma – Google News

February 20, 2012

Hospital reports gains vs. asthma – Boston Globe

Hospital reports gains vs. asthma
Boston Globe
Hospitalizations for asthma have been dramatically cut by a program that helps families reduce the conditions that trigger attacks, saving $1.46 in hospital care for every $1 spent on prevention, according to a Children's Hospital Boston study being …
Home Visits for Asthma: A win for Both Patients and PayersMarketWatch (press release)

all 7 news articles »

View full post on asthma – Google News

November 8, 2011

Halozyme Therapeutics Reports Third Quarter 2011 Financial Results – PR Newswire (press release)

Halozyme Therapeutics Reports Third Quarter 2011 Financial Results
PR Newswire (press release)
Baxter presented its Phase III data for the HyQ program at the American College of Allergy, Asthma & Immunology. HyQ was shown to be effective in subjects with Primary Immunodeficiency and enabled 94% of subjects to receive full 3 or 4-weekly doses of …
Baxter Presents Phase III HyQ Efficacy and Tolerability Data at American …MarketWatch (press release)

all 27 news articles »

View full post on asthma – Google News

August 8, 2011

Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal … – MarketWatch (press release)

Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal …
MarketWatch (press release)
In addition, Array initiated new clinical trials for two proprietary anti-inflammatory drugs: ARRY-797 for pain and ARRY-502 for asthma. ARRY-797 is being tested in a 150-patient Phase 2 chronic pain trial in osteoarthritis (OA) patients with top-line …

and more »

View full post on asthma – Google News

May 19, 2011